Browsing Tag
Cellares
3 posts
Why Cellares is cutting 100 jobs after Bristol Myers ends $380m CAR-T deal
Cellares will permanently eliminate 100 South San Francisco positions after Bristol Myers Squibb terminated a manufacturing partnership worth up to $380 million, saying the Cell Shuttle platform could not meet commercial Breyanzi requirements, an assessment Cellares disputes.
TScan launches Phase 3 ALLOHA-2 with $128m in cash and a looming funding gap
TSC-101 enters Phase 3 as TScan weighs promising donor-chimerism data against manufacturing complexity and a pre-readout funding gap.
Cell therapy in solid tumors: Breakthroughs, delivery challenges, and what’s next
Discover how new trials and biotech innovations are tackling the biggest hurdles in adapting cell therapy for solid tumors. See what’s changing now.